The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients

被引：20

作者：

Chew, CG ^{[1
]}

Meise, MD ^{[1
]}

Disney, APS ^{[1
]}

机构：

[1] Queen Elizabeth Hosp, Renal Unit, Woodville, SA 5011, Australia

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1999年 / 14卷 / 08期

关键词：

D O I：

10.1093/ndt/14.8.2047

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：2047 / 2049

页数：3

共 14 条

[1]

ABERHARD J, 1990, TRANSPLANTATION, V50, P613

[2]

COATES PM, ERYTHROPOIETIN, P60

[3]

CONLON PJ, 1994, NEPHROL DIAL TRANSPL, V9, P1358

[4] Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: Possible implications of angiotensin-converting enzyme inhibitors [J].

Erturk, S ;

Ates, K ;

Duman, N ;

Karatan, O ;

Erbay, B ;

Ertug, E .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (02) :396-397

[5] Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients? [J].

Hess, E ;

Sperschneider, H ;

Stein, G .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (04) :749-751

[6]

HIRAKATA H, 1986, CLIN NEPHROL, V26, P27

[7] WORSENING OF ANEMIA INDUCED BY LONG-TERM USE OF CAPTOPRIL IN HEMODIALYSIS-PATIENTS [J].

HIRAKATA, H ;

ONOYAMA, K ;

ISEKI, K ;

KUMAGAI, H ;

FUJIMI, S ;

OMAE, T .

AMERICAN JOURNAL OF NEPHROLOGY, 1984, 4 (06) :355-360

[8] Losartan, an angiotensin-II receptor antagonist reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis [J].

Klaassen, RJL ;

VanGelder, T ;

RischenVos, J ;

Deinum, J ;

ManintVeld, AJ ;

Weimar, W .

TRANSPLANTATION, 1997, 64 (05) :780-782

[9]

KUPIN W, 1997, TRANSPLANT P, P207

[10] ASSOCIATION OF POSTRENAL TRANSPLANT ERYTHROCYTOSIS AND MICROALBUMINURIA - RESPONSE TO ANGIOTENSIN-CONVERTING ENZYME-INHIBITION [J].

MULHERN, JG ;

LIPKOWITZ, GS ;

BRADEN, GL ;

MADDEN, RL ;

OSHEA, MH ;

HARVILCHUCK, H ;

GUARNERA, JM ;

GERMAIN, MJ .

AMERICAN JOURNAL OF NEPHROLOGY, 1995, 15 (04) :318-322

← 1 2 →